The risk of bias across studies was, by design, maximum for blinding of care providers, possibly significant for the randomisation and allocation concealment procedures ( Appendix Figure 7).
← all excerpts
Using Bayesian statistics to estimate the likelihood a new trial will demonstrate the efficacy of a new treatment.
1
—
—